Locate Bio has raised £9.2 million to fund a clinical study of LDGraft, a bone graft substitute for spinal fusion. The funding comes from both new investors and existing investors, Mercia Ventures and BGF.  Locate Bio, a spinout from the University of Nottingham, says it marks a significant milestone in its mission to relieve suffering … Continue reading Locate Bio raises £9.2m to develop bone graft substitute